Metabolic Disease
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
LongeveronPeripheral Intravenous
BayerNo drug
Clinical Trials (2)
Total enrollment: 796 patients across 2 trials
Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial
Start: Dec 2023Est. completion: Dec 20230
Phase 2Withdrawn
Study To Assess the Dietary Carbohydrate Content of Indian Diabetic Population
Start: May 2012Est. completion: Sep 2012796 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space